ADHD and Life Expectancy: What "Years Shorter" Actually Measures

**Research review** ## Hook "People with ADHD die 9 to 11 years earlier" travels fast. Behind that line is a difference between model estimates, not a forecast for any one person. Here is what the researchers actually compared. ## Key points - A large UK cohort estimated the gap in life expectancy for adults with a diagnosis of ADHD at 6.78 years for men and 8.64 years for women (95% CI 4.50–9.11 and 6.55–10.91) [observation, S-001]. - This is an observational association, not a proven cause. The data came from primary-care records, not from an experiment [design limit, S-001]. - A 2026 meta-analysis of 19 studies links ADHD to higher all-cause mortality (HR 1.71) and reports substantial heterogeneity between studies [review, S-002]. - In the same pooled data, ADHD medication use was associated with lower all-cause mortality (HR 0.75). That is also observational, not a randomised comparison [review, S-002]. - None of these numbers tells an individual with ADHD to change their treatment. Those decisions belong with a clinician. ## What was compared S-001 drew on around 792 UK general practices between 2000 and 2019. It compared 30,039 adults aged 18+ with a recorded ADHD diagnosis against 300,390 people matched 1:10 [S-001]. Life expectancy was compared using model estimates. The "gap" in years is a difference between model estimates, not a count of how long a given person will live. ## Why this is not "ADHD shortens your life" The authors write that the apparent gap may reflect modifiable risk factors, and they present that as a possibility, not a finding. An observational design cannot separate the effect of the diagnosis from everything else that comes with it: lifestyle, other conditions, access to care, and how diagnoses were recorded. Specific causes (cardiovascular disease, anxiety, substance dependence) often show up in summaries, but the abstracts we checked do not name them. This article does not claim them. They are open questions for the full texts. ## What the meta-analysis adds The 2026 meta-analysis pooled 19 studies and more than 15 million participants. All-cause mortality was higher in people with ADHD (HR 1.71, 95% CI 1.31–2.24), with associations also reported for suicide and natural-cause death [S-002]. Heterogeneity was substantial. Studies differ in country, method and confounder control, so one average figure does not describe everyone with ADHD. ## What is known, unknown, and the risks **Known:** in large observational datasets, people with a recorded ADHD diagnosis have a higher risk of earlier death [S-001, S-002]. **Unknown:** why. Whether the link comes from ADHD itself, from co-occurring conditions, or from differences in care is not settled by these sources. **Not supported by these sources:** that ADHD shortens life by a specific number of years; that treatment extends any individual's life; that supplements or foods can replace diagnosis and treatment. **Risks:** do not change prescribed treatment based on this article, including stopping medication. ADHD diagnosis and treatment are decided with a doctor. This material is not medical advice and does not replace a consultation with a physician. ## What next If you or someone close to you is worried about ADHD and long-term health, raise it with a GP or psychiatrist. Useful questions: which co-occurring conditions should be screened, how to monitor physical health with ADHD, and which risks matter most in your case. ## Question for readers Which ADHD and health questions would you like us to cover next? Share them in the comments, and bring medical decisions to a clinician. ## What was verified and what was meant | Claim | Status | Source | |---|---|---| | UK matched cohort: life-expectancy gap of 6.78 years (men) and 8.64 years (women) | checked against the abstract snapshot; full text not compared line by line | S-001 | | Sample of 30,039 adults with ADHD and 300,390 matched comparators from 792 practices | checked against the abstract snapshot | S-001 | | The gap may reflect modifiable risk factors | the authors' hypothesis, not an established cause | S-001 | | Specific causes (cardiovascular, anxiety, dependence) | not confirmed by the abstracts; not claimed | — | | Meta-analysis: all-cause mortality HR 1.71 (1.31–2.24), 19 studies | checked against the abstract snapshot | S-002 | | Medication use associated with HR 0.75 (0.64–0.87) | observational association, not a causal effect; checked against the abstract | S-002 | | Substantial heterogeneity | checked against the abstract | S-002 | The 2025 archive post said "9 years for men and 11 for women" and "300 thousand records." This article uses the figures from the primary source instead. No medical reviewer is assigned yet; no medical review date is recorded. **Author:** Serge Luboff. This material is not medical advice and does not replace a consultation with a physician.